APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acrivastine Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acrivastine Capsules Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchAcrivastine Capsules Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acrivastine Capsules Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Acrivastine Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acrivastine Capsules Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Acrivastine Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Acrivastine Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Acrivastine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acrivastine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acrivastine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acrivastine Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Acrivastine Capsules include Actient Pharmaceuticals, Benadryl, Brown & Burk UK, McNeil Laboratories, The Wellcome Foundation and Chongqing Huapont Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Acrivastine Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acrivastine Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Acrivastine Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acrivastine Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acrivastine Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Acrivastine Capsules sales, projected growth trends, production technology, application and end-user industry.

Acrivastine Capsules Segment by Company

Actient Pharmaceuticals

Benadryl

Brown & Burk UK

McNeil Laboratories

The Wellcome Foundation

Chongqing Huapont Pharmaceutical

Acrivastine Capsules Segment by Type

24 Capsules/Box

20 Capsules/Box

12 Capsules/Box

Acrivastine Capsules Segment by Application

Hospital

Clinic

Acrivastine Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acrivastine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acrivastine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acrivastine Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Acrivastine Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Acrivastine Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acrivastine Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acrivastine Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 24 Capsules/Box Major Manufacturers Table 3. 20 Capsules/Box Major Manufacturers Table 4. 12 Capsules/Box Major Manufacturers Table 5. Global Acrivastine Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Acrivastine Capsules Industry Trends Table 9. Acrivastine Capsules Industry Drivers Table 10. Acrivastine Capsules Industry Opportunities and Challenges Table 11. Acrivastine Capsules Industry Restraints Table 12. Global Acrivastine Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Acrivastine Capsules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Acrivastine Capsules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Acrivastine Capsules Revenue Market Share by Region (2021-2026) Table 16. Global Acrivastine Capsules Revenue Market Share by Region (2027-2032) Table 17. Global Acrivastine Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Acrivastine Capsules Sales by Region (2021-2026) & (k units) Table 19. Global Acrivastine Capsules Sales by Region (2027-2032) & (k units) Table 20. Global Acrivastine Capsules Sales Market Share by Region (2021-2026) Table 21. Global Acrivastine Capsules Sales Market Share by Region (2027-2032) Table 22. Global Acrivastine Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Acrivastine Capsules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Acrivastine Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Acrivastine Capsules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Acrivastine Capsules Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Acrivastine Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Acrivastine Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Acrivastine Capsules Manufacturers, Product Type & Application Table 30. Global Acrivastine Capsules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Acrivastine Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Acrivastine Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Acrivastine Capsules Revenue Market Share by Type (2021-2026) Table 37. Global Acrivastine Capsules Revenue Market Share by Type (2027-2032) Table 38. Global Acrivastine Capsules Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 40. Global Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 41. Global Acrivastine Capsules Sales Market Share by Type (2021-2026) Table 42. Global Acrivastine Capsules Sales Market Share by Type (2027-2032) Table 43. Global Acrivastine Capsules Price by Type (2021-2026) & (US$/unit) Table 44. Global Acrivastine Capsules Price by Type (2027-2032) & (US$/unit) Table 45. Global Acrivastine Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Acrivastine Capsules Revenue Market Share by Application (2021-2026) Table 49. Global Acrivastine Capsules Revenue Market Share by Application (2027-2032) Table 50. Global Acrivastine Capsules Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 52. Global Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 53. Global Acrivastine Capsules Sales Market Share by Application (2021-2026) Table 54. Global Acrivastine Capsules Sales Market Share by Application (2027-2032) Table 55. Global Acrivastine Capsules Price by Application (2021-2026) & (US$/unit) Table 56. Global Acrivastine Capsules Price by Application (2027-2032) & (US$/unit) Table 57. Actient Pharmaceuticals Company Information Table 58. Actient Pharmaceuticals Business Overview Table 59. Actient Pharmaceuticals Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Actient Pharmaceuticals Acrivastine Capsules Product Portfolio Table 61. Actient Pharmaceuticals Recent Development Table 62. Benadryl Company Information Table 63. Benadryl Business Overview Table 64. Benadryl Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Benadryl Acrivastine Capsules Product Portfolio Table 66. Benadryl Recent Development Table 67. Brown & Burk UK Company Information Table 68. Brown & Burk UK Business Overview Table 69. Brown & Burk UK Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Brown & Burk UK Acrivastine Capsules Product Portfolio Table 71. Brown & Burk UK Recent Development Table 72. McNeil Laboratories Company Information Table 73. McNeil Laboratories Business Overview Table 74. McNeil Laboratories Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. McNeil Laboratories Acrivastine Capsules Product Portfolio Table 76. McNeil Laboratories Recent Development Table 77. The Wellcome Foundation Company Information Table 78. The Wellcome Foundation Business Overview Table 79. The Wellcome Foundation Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. The Wellcome Foundation Acrivastine Capsules Product Portfolio Table 81. The Wellcome Foundation Recent Development Table 82. Chongqing Huapont Pharmaceutical Company Information Table 83. Chongqing Huapont Pharmaceutical Business Overview Table 84. Chongqing Huapont Pharmaceutical Acrivastine Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Chongqing Huapont Pharmaceutical Acrivastine Capsules Product Portfolio Table 86. Chongqing Huapont Pharmaceutical Recent Development Table 87. North America Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 90. North America Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 91. North America Acrivastine Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 92. North America Acrivastine Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 93. North America Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 96. North America Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 97. North America Acrivastine Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 98. North America Acrivastine Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 99. North America Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Acrivastine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Acrivastine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. North America Acrivastine Capsules Sales by Country (2021-2026) & (k units) Table 104. North America Acrivastine Capsules Sales by Country (2027-2032) & (k units) Table 105. North America Acrivastine Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 106. North America Acrivastine Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 107. United States Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 108. Canada Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 109. Mexico Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 110. Europe Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 113. Europe Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 114. Europe Acrivastine Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 115. Europe Acrivastine Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 116. Europe Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 119. Europe Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 120. Europe Acrivastine Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 121. Europe Acrivastine Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 122. Europe Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Acrivastine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Acrivastine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 126. Europe Acrivastine Capsules Sales by Country (2021-2026) & (k units) Table 127. Europe Acrivastine Capsules Sales by Country (2027-2032) & (k units) Table 128. Europe Acrivastine Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 129. Europe Acrivastine Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 130. Germany Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 131. France Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 132. U.K. Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 133. Italy Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 134. Russia Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 135. Spain Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 138. Sweden Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 139. Poland Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 140. China Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 141. China Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 142. China Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 143. China Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 144. China Acrivastine Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 145. China Acrivastine Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 146. China Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 147. China Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 148. China Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 149. China Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 150. China Acrivastine Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 151. China Acrivastine Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 152. Asia Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 155. Asia Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 156. Asia Acrivastine Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 157. Asia Acrivastine Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 158. Asia Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 161. Asia Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 162. Asia Acrivastine Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 163. Asia Acrivastine Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Acrivastine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Acrivastine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Asia Acrivastine Capsules Sales by Country (2021-2026) & (k units) Table 169. Asia Acrivastine Capsules Sales by Country (2027-2032) & (k units) Table 170. Asia Acrivastine Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 171. Asia Acrivastine Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 172. Japan Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 173. South Korea Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 174. India Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 175. Australia Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Acrivastine Capsules Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Acrivastine Capsules Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Acrivastine Capsules Sales by Type (2021-2026) & (k units) Table 181. SAMEA Acrivastine Capsules Sales by Type (2027-2032) & (k units) Table 182. SAMEA Acrivastine Capsules Sales Price by Type (2021-2026) & (US$/unit) Table 183. SAMEA Acrivastine Capsules Sales Price by Type (2027-2032) & (US$/unit) Table 184. SAMEA Acrivastine Capsules Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Acrivastine Capsules Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Acrivastine Capsules Sales by Application (2021-2026) & (k units) Table 187. SAMEA Acrivastine Capsules Sales by Application (2027-2032) & (k units) Table 188. SAMEA Acrivastine Capsules Sales Price by Application (2021-2026) & (US$/unit) Table 189. SAMEA Acrivastine Capsules Sales Price by Application (2027-2032) & (US$/unit) Table 190. SAMEA Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Acrivastine Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Acrivastine Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. SAMEA Acrivastine Capsules Sales by Country (2021-2026) & (k units) Table 195. SAMEA Acrivastine Capsules Sales by Country (2027-2032) & (k units) Table 196. SAMEA Acrivastine Capsules Sales Price by Country (2021-2026) & (US$/unit) Table 197. SAMEA Acrivastine Capsules Sales Price by Country (2027-2032) & (US$/unit) Table 198. Brazil Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 199. Argentina Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 200. Chile Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 201. Colombia Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 202. Peru Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 204. Israel Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 205. UAE Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 206. Turkey Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 207. Iran Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 208. Egypt Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Acrivastine Capsules Distributors List Table 212. Acrivastine Capsules Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Acrivastine Capsules Image Figure 2. Global Acrivastine Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acrivastine Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 24 Capsules/Box Image Figure 5. 20 Capsules/Box Image Figure 6. 12 Capsules/Box Image Figure 7. Global Acrivastine Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Acrivastine Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Acrivastine Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Acrivastine Capsules Revenue (2021-2032) & (US$ Million) Figure 13. Global Acrivastine Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Acrivastine Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Acrivastine Capsules Revenue Market Share by Region (2021-2032) Figure 16. Global Acrivastine Capsules Sales (2021-2032) & (k units) Figure 17. Global Acrivastine Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Acrivastine Capsules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Acrivastine Capsules Sales YoY (2021-2032) & (k units) Figure 20. Europe Acrivastine Capsules Sales YoY (2021-2032) & (k units) Figure 21. China Acrivastine Capsules Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Acrivastine Capsules Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Acrivastine Capsules Sales YoY (2021-2032) & (k units) Figure 24. Global Acrivastine Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Acrivastine Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Acrivastine Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Acrivastine Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Acrivastine Capsules Revenue Market Share by Type (2021-2032) Figure 30. Global Acrivastine Capsules Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Acrivastine Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Acrivastine Capsules Sales Market Share by Type (2021-2032) Figure 33. Global Acrivastine Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Acrivastine Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Acrivastine Capsules Revenue Market Share by Application (2021-2032) Figure 36. Global Acrivastine Capsules Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Acrivastine Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Acrivastine Capsules Sales Market Share by Application (2021-2032) Figure 39. North America Acrivastine Capsules Revenue Share by Type (2021-2032) Figure 40. North America Acrivastine Capsules Sales Share by Type (2021-2032) Figure 41. North America Acrivastine Capsules Revenue Share by Application (2021-2032) Figure 42. North America Acrivastine Capsules Sales Share by Application (2021-2032) Figure 43. North America Acrivastine Capsules Revenue Share by Country (2021-2032) Figure 44. North America Acrivastine Capsules Sales Share by Country (2021-2032) Figure 45. Europe Acrivastine Capsules Revenue Share by Type (2021-2032) Figure 46. Europe Acrivastine Capsules Sales Share by Type (2021-2032) Figure 47. Europe Acrivastine Capsules Revenue Share by Application (2021-2032) Figure 48. Europe Acrivastine Capsules Sales Share by Application (2021-2032) Figure 49. Europe Acrivastine Capsules Revenue Share by Country (2021-2032) Figure 50. Europe Acrivastine Capsules Sales Share by Country (2021-2032) Figure 51. China Acrivastine Capsules Revenue Share by Type (2021-2032) Figure 52. China Acrivastine Capsules Sales Share by Type (2021-2032) Figure 53. China Acrivastine Capsules Revenue Share by Application (2021-2032) Figure 54. China Acrivastine Capsules Sales Share by Application (2021-2032) Figure 55. Asia Acrivastine Capsules Revenue Share by Type (2021-2032) Figure 56. Asia Acrivastine Capsules Sales Share by Type (2021-2032) Figure 57. Asia Acrivastine Capsules Revenue Share by Application (2021-2032) Figure 58. Asia Acrivastine Capsules Sales Share by Application (2021-2032) Figure 59. Asia Acrivastine Capsules Revenue Share by Country (2021-2032) Figure 60. Asia Acrivastine Capsules Sales Share by Country (2021-2032) Figure 61. SAMEA Acrivastine Capsules Revenue Share by Type (2021-2032) Figure 62. SAMEA Acrivastine Capsules Sales Share by Type (2021-2032) Figure 63. SAMEA Acrivastine Capsules Revenue Share by Application (2021-2032) Figure 64. SAMEA Acrivastine Capsules Sales Share by Application (2021-2032) Figure 65. SAMEA Acrivastine Capsules Revenue Share by Country (2021-2032) Figure 66. SAMEA Acrivastine Capsules Sales Share by Country (2021-2032) Figure 67. Acrivastine Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Acrivastine Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 24 Capsules/Box
  • 20 Capsules/Box
  • 12 Capsules/Box
Applications
  • Hospital
  • Clinic
Companies covered
  • Actient Pharmaceuticals
  • Benadryl
  • Brown & Burk UK
  • McNeil Laboratories
  • The Wellcome Foundation
  • Chongqing Huapont Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acrivastine Capsules Market by Type
  3. 1.2.1 Global Acrivastine Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 24 Capsules/Box
  5. 1.2.3 20 Capsules/Box
  6. 1.2.4 12 Capsules/Box
  7. 1.3 Acrivastine Capsules Market by Application
  8. 1.3.1 Global Acrivastine Capsules Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Acrivastine Capsules Market Dynamics
  1. 2.1 Acrivastine Capsules Industry Trends
  2. 2.2 Acrivastine Capsules Industry Drivers
  3. 2.3 Acrivastine Capsules Industry Opportunities and Challenges
  4. 2.4 Acrivastine Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Acrivastine Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Acrivastine Capsules Revenue by Region
  3. 3.2.1 Global Acrivastine Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acrivastine Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Acrivastine Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Acrivastine Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Acrivastine Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Acrivastine Capsules Sales by Region
  9. 3.4.1 Global Acrivastine Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Acrivastine Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Acrivastine Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Acrivastine Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Acrivastine Capsules Revenue by Manufacturers
  2. 4.1.1 Global Acrivastine Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Acrivastine Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Acrivastine Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acrivastine Capsules Sales by Manufacturers
  6. 4.2.1 Global Acrivastine Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Acrivastine Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Acrivastine Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Acrivastine Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Acrivastine Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Acrivastine Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Acrivastine Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Acrivastine Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Acrivastine Capsules Market CR5 and HHI
  16. 4.8.2 2025 Acrivastine Capsules Tier 1, Tier 2, and Tier 3
5 Acrivastine Capsules Market by Type
  1. 5.1 Global Acrivastine Capsules Revenue by Type
  2. 5.1.1 Global Acrivastine Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Acrivastine Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Acrivastine Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Acrivastine Capsules Sales by Type
  6. 5.2.1 Global Acrivastine Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acrivastine Capsules Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Acrivastine Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Acrivastine Capsules Price by Type
6 Acrivastine Capsules Market by Application
  1. 6.1 Global Acrivastine Capsules Revenue by Application
  2. 6.1.1 Global Acrivastine Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Acrivastine Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Acrivastine Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Acrivastine Capsules Sales by Application
  6. 6.2.1 Global Acrivastine Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Acrivastine Capsules Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Acrivastine Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Acrivastine Capsules Price by Application
7 Company Profiles
  1. 7.1 Actient Pharmaceuticals
  2. 7.1.1 Actient Pharmaceuticals Company Information
  3. 7.1.2 Actient Pharmaceuticals Business Overview
  4. 7.1.3 Actient Pharmaceuticals Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actient Pharmaceuticals Acrivastine Capsules Product Portfolio
  6. 7.1.5 Actient Pharmaceuticals Recent Developments
  7. 7.2 Benadryl
  8. 7.2.1 Benadryl Company Information
  9. 7.2.2 Benadryl Business Overview
  10. 7.2.3 Benadryl Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Benadryl Acrivastine Capsules Product Portfolio
  12. 7.2.5 Benadryl Recent Developments
  13. 7.3 Brown & Burk UK
  14. 7.3.1 Brown & Burk UK Company Information
  15. 7.3.2 Brown & Burk UK Business Overview
  16. 7.3.3 Brown & Burk UK Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Brown & Burk UK Acrivastine Capsules Product Portfolio
  18. 7.3.5 Brown & Burk UK Recent Developments
  19. 7.4 McNeil Laboratories
  20. 7.4.1 McNeil Laboratories Company Information
  21. 7.4.2 McNeil Laboratories Business Overview
  22. 7.4.3 McNeil Laboratories Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 McNeil Laboratories Acrivastine Capsules Product Portfolio
  24. 7.4.5 McNeil Laboratories Recent Developments
  25. 7.5 The Wellcome Foundation
  26. 7.5.1 The Wellcome Foundation Company Information
  27. 7.5.2 The Wellcome Foundation Business Overview
  28. 7.5.3 The Wellcome Foundation Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 The Wellcome Foundation Acrivastine Capsules Product Portfolio
  30. 7.5.5 The Wellcome Foundation Recent Developments
  31. 7.6 Chongqing Huapont Pharmaceutical
  32. 7.6.1 Chongqing Huapont Pharmaceutical Company Information
  33. 7.6.2 Chongqing Huapont Pharmaceutical Business Overview
  34. 7.6.3 Chongqing Huapont Pharmaceutical Acrivastine Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Chongqing Huapont Pharmaceutical Acrivastine Capsules Product Portfolio
  36. 7.6.5 Chongqing Huapont Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Acrivastine Capsules Market Size by Type
  2. 8.1.1 North America Acrivastine Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Acrivastine Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Acrivastine Capsules Price by Type (2021-2032)
  5. 8.2 North America Acrivastine Capsules Market Size by Application
  6. 8.2.1 North America Acrivastine Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Acrivastine Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Acrivastine Capsules Price by Application (2021-2032)
  9. 8.3 North America Acrivastine Capsules Market Size by Country
  10. 8.3.1 North America Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Acrivastine Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Acrivastine Capsules Market Size by Type
  2. 9.1.1 Europe Acrivastine Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Acrivastine Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Acrivastine Capsules Price by Type (2021-2032)
  5. 9.2 Europe Acrivastine Capsules Market Size by Application
  6. 9.2.1 Europe Acrivastine Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Acrivastine Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Acrivastine Capsules Price by Application (2021-2032)
  9. 9.3 Europe Acrivastine Capsules Market Size by Country
  10. 9.3.1 Europe Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Acrivastine Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Acrivastine Capsules Market Size by Type
  2. 10.1.1 China Acrivastine Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Acrivastine Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Acrivastine Capsules Price by Type (2021-2032)
  5. 10.2 China Acrivastine Capsules Market Size by Application
  6. 10.2.1 China Acrivastine Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Acrivastine Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Acrivastine Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acrivastine Capsules Market Size by Type
  2. 11.1.1 Asia Acrivastine Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Acrivastine Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Acrivastine Capsules Price by Type (2021-2032)
  5. 11.2 Asia Acrivastine Capsules Market Size by Application
  6. 11.2.1 Asia Acrivastine Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Acrivastine Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Acrivastine Capsules Price by Application (2021-2032)
  9. 11.3 Asia Acrivastine Capsules Market Size by Country
  10. 11.3.1 Asia Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Acrivastine Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acrivastine Capsules Market Size by Type
  2. 12.1.1 SAMEA Acrivastine Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Acrivastine Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Acrivastine Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Acrivastine Capsules Market Size by Application
  6. 12.2.1 SAMEA Acrivastine Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Acrivastine Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Acrivastine Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Acrivastine Capsules Market Size by Country
  10. 12.3.1 SAMEA Acrivastine Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Acrivastine Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Acrivastine Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Acrivastine Capsules Value Chain Analysis
  2. 13.1.1 Acrivastine Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Acrivastine Capsules Production Mode & Process
  6. 13.2 Acrivastine Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Acrivastine Capsules Distributors
  9. 13.2.3 Acrivastine Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst